EUVIMEDEUVIMED entdecken
Crossref

Multifactorial Mechanisms and Therapeutic Role of the Gut Microbiota in Sarcopenic Obesity: Role of Lifestyle and Gut Microbiota–Derived Metabolites

Yimei Tao iD, Zhaoxiang Wang, Qianqian Wang, Shao Zhong

Nutrition Reviews · 13.01.2026

DOI: 10.1093/nutrit/nuaf274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition Reviews, online erschienen am 13.01.2026. Verfasst von Yimei Tao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Gusu School, Nanjing Medical University, The First People's Hospital of Kunshan, Jiangsu, Kunshan 215300, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 179 Literaturangaben. Gefördert von: Suzhou Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenic obesity (SO), a pathological interplay of muscle atrophy and excessive adiposity, poses increasing health risks in aging individuals. This review elucidates the multifactorial role of the gut microbiota (GM) in SO pathogenesis, emphasizing novel mechanisms linking GM dysbiosis to impaired muscle–lipid homeostasis. We emphasize how a Western diet and a sedentary lifestyle contribute to alterations in the GM composition, leading to changes in metabolic products, such as reduced short-chain fatty acids and increased production of lipopolysaccharides (LPS). These changes drive systemic inflammation, increased intestinal permeability, and metabolic dysfunction in adipose tissue and skeletal muscle. Emerging interventions, including next-generation probiotics, prebiotics, and glucagon-like peptide-1 receptor agonists (GLP-1RAs), demonstrate therapeutic potential. Our synthesis highlights GM as a pivotal therapeutic target, suggesting that personalized strategies combining microbiota modulation, dietary optimization, and exercise can be used to counteract SO. This work provides mechanistic insights into translational applications, offering a roadmap for innovative, microbiota-centric interventions to improve aging-related metabolic and muscle health.

Schlagwörter

Stichwörter der Autor:innen

gut microbiotaobesityprobioticssarcopeniasarcopenic obesity

Autor:innen und Institutionen

  • Department of Endocrinology, Gusu School, Nanjing Medical University, The First People's Hospital of Kunshan, Jiangsu, Kunshan 215300, China.
  • Department of Endocrinology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu 215300, China.
  • Department of Endocrinology, Kunshan Hospital (affiliated with Jiangsu University), Kunshan 215300, China.

ORCID-Profile: Yimei Tao

Förderung

  • Suzhou Science and Technology Project

Zitieren

APA

Tao, Y., Wang, Z., Wang, Q., & Zhong, S. (2026). Multifactorial Mechanisms and Therapeutic Role of the Gut Microbiota in Sarcopenic Obesity: Role of Lifestyle and Gut Microbiota–Derived Metabolites. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuaf274

Vancouver

Tao Y, Wang Z, Wang Q, Zhong S. Multifactorial Mechanisms and Therapeutic Role of the Gut Microbiota in Sarcopenic Obesity: Role of Lifestyle and Gut Microbiota–Derived Metabolites. Nutrition Reviews. 2026. doi:10.1093/nutrit/nuaf274

BibTeX
@article{Tao2026,
  author = {Tao, Yimei and Wang, Zhaoxiang and Wang, Qianqian and Zhong, Shao},
  title = {Multifactorial Mechanisms and Therapeutic Role of the Gut Microbiota in Sarcopenic Obesity: Role of Lifestyle and Gut Microbiota–Derived Metabolites},
  journal = {Nutrition Reviews},
  year = {2026},
  doi = {10.1093/nutrit/nuaf274}
}
Kostenlos starten →